Gene: KDM4C
Official Full Name: lysine demethylase 4Cprovided by HGNC
Gene Summary: This gene is a member of the Jumonji domain 2 (JMJD2) family. The encoded protein is a trimethylation-specific demethylase, and converts specific trimethylated histone residues to the dimethylated form. This enzymatic action regulates gene expression and chromosome segregation. Chromosomal aberrations and changes in expression of this gene may be found in tumor cells. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2015]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO06087 | KDM4C Knockout cell line (HeLa) | Human | KDM4C | 1:3~1:6 | Negative | Online Inquiry |
KO06088 | KDM4C Knockout cell line (HCT 116) | Human | KDM4C | 1:2~1:4 | Negative | Online Inquiry |
KO06089 | KDM4C Knockout cell line (HEK293) | Human | KDM4C | 1:3~1:6 | Negative | Online Inquiry |
KO06090 | KDM4C Knockout cell line (A549) | Human | KDM4C | 1:3~1:4 | Negative | Online Inquiry |
KDM4C Gene Knockout Cell Lines are genetically engineered cellular models that exhibit targeted deletions of the KDM4C gene, which encodes for a histone demethylase implicated in the regulation of gene expression through the modification of histones. These knockout cell lines serve as vital tools in elucidating the role of KDM4C in epigenetic regulation, cellular metabolism, and tumorigenesis. By removing the KDM4C gene, researchers can investigate the downstream effects on gene expression profiles, cellular behavior, and responses to various stimuli.
The primary mechanism through which KDM4C operates involves its enzymatic activity, which selectively demethylates tri- and dimethylated lysine 9 and lysine 36 on histone H3. This modification plays a crucial role in the transition between active and inactive chromatin states, influencing transcriptional activation and silencing. With precise knockout models, scientists can conduct experiments to determine how KDM4C modulates these processes, opening avenues for therapeutic intervention in diseases such as cancer.
In research and clinical settings, KDM4C Gene Knockout Cell Lines are particularly valuable for studying epigenetic modifications and their implications in disease progression. They provide a platform for drug discovery efforts aimed at reprogramming epigenetic landscapes and delivering insights into potential therapeutic targets.
Compared to other gene knockout models, KDM4C Gene Knockout Cell Lines offer unparalleled specificity and reproducibility, facilitating the generation of high-quality, publishable data. Their unique ability to mimic the physiological loss-of-function context provides a significant advantage over non-specific inhibitors, reducing the risk of off-target effects and allowing for a clearer interpretation of results.
For researchers and clinicians focused on the burgeoning field of epigenetics, these cell lines represent a critical resource to advance scientific understanding and therapeutic strategies. Our company prides itself on delivering high-quality, optimized biological products backed by extensive research and a commitment to excellence in the life sciences field. We strive to empower the scientific community with innovative solutions that propel breakthroughs in health and disease.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.